Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats

This study aimed to explore the potential mechanisms of Qishen Yiqi dripping pill (QYDP) against diabetic nephropathy (DN) through network pharmacology and animal experiments. The components and targets of QYDP and DN-related targets were retrieved from public databases. A total of 116 compounds and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shaohua, Xu, Guangbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232344/
https://www.ncbi.nlm.nih.gov/pubmed/35754685
http://dx.doi.org/10.1155/2022/6239829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232344/
https://www.ncbi.nlm.nih.gov/pubmed/35754685
http://dx.doi.org/10.1155/2022/6239829

Ejemplares similares